明胶球与不规则明胶海绵颗粒在肝细胞癌常规经导管动脉化疗栓塞中的比较
单中心回顾性研究纳入368例肝细胞癌患者,比较明胶球(GS)与不规则明胶海绵颗粒(GP)行常规经导管动脉化疗栓塞的疗效、不良事件及肝动脉损伤(HAI)。两组肿瘤缓解与局部复发无显著差异,但GP组HAI发生率显著更高(37.4% vs 16%),肿瘤≥3 cm和使用GP是HAI的危险因素。
要点
- GS组与GP组完全缓解率73.3% vs 70.9%、总体缓解率99.4% vs 98.5%,均无显著差异。
- GP组肝动脉损伤发生率37.4%(49/131)显著高于GS组16%(20/125),P<0.001。
- 肝动脉损伤危险因素为索引肿瘤≥3 cm(P=0.001)和使用GP(P<0.001)。
核心结论
- GS行C-TACE的疗效和不良事件与不规则GP相同,但所致肝动脉损伤显著更少。
研究设计与样本
- 单中心回顾性研究,纳入2019年9月至2021年5月连续368例接受C-TACE的肝细胞癌患者,GS组165例、GP组203例,均行亚段性C-TACE。
关键影像表现/征象
- GS组与GP组完全缓解率分别为73.3%和70.9%,总体肿瘤缓解率分别为99.4%和98.5%,组间无显著差异(P=0.642和P=0.631)。
- GS组与GP组累积局部肿瘤复发率无显著差异(P=0.558)。
- GS组肝动脉损伤发生率为16%(125例中20例),GP组为37.4%(131例中49例),GP组显著高于GS组(P<0.001)。
诊断标准与关键数值
- 多因素logistic回归显示肝动脉损伤的危险因素为索引肿瘤大小≥3 cm(P=0.001)和使用GP(P<0.001)。
- 不良事件发生率组间无显著差异(P=0.231)。
临床应用与阅片要点
- 使用明胶球行C-TACE可获得与不规则明胶海绵颗粒相同的肿瘤缓解和不良事件结果,且肝动脉损伤更少。
- 索引肿瘤≥3 cm或使用不规则明胶海绵颗粒时,肝动脉损伤风险更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the therapeutic effect, adverse events, and hepatic artery injury (HAI) between gelatin spheres (GS) and nonspherical gelatin sponge particles (GP) in conventional transcatheter arterial chemoembolization (C-TACE).
MATERIALS AND METHODS: A total of 368 consecutive patients with hepatocellular carcinoma (HCC) who underwent C-TACE between September 2019 and May 2021 were included in this single center retrospective study. Adverse events, radiologic tumor response, local tumor recurrence, and HAI were evaluated.
RESULTS: Subsegmental C-TACE was performed using biodegradable GS in 165 patients and nonspherical biodegradable GP in 203 patients. No significant differences in patient background existed between the groups, and there was no significant difference in adverse event rate (p = 0.231). The CR and overall tumor response in the GS and GP groups were 73.3% vs 70.9%, and 99.4% vs 98.5%, respectively, with no significant between-group differences (p = 0.642 and p = 0.631). No significant difference in cumulative local tumor recurrence rate existed between the groups (p = 0.558). HAI was observed in 16% (20 of 125 patients) in the GS group and 37.4% (49 of 131 patients) in the GP group. The incidence of HAI was significantly higher in the GP group than in the GS group (p < 0.001). In multiple logistic regression analysis, risk factors for HAI were index tumor size ≥ 3 cm (p = 0.001) and use of GP (p < 0.001).
CONCLUSION: C-TACE with GS resulted in the same therapeutic and adverse effects as C-TACE with nonspherical GP while causing significantly less HAI.
KEY POINTS: Question Comparisons between GS and nonspherical GP are lacking, and the potential advantages of GS over nonspherical GP are not well studied. Findings HAI incidence was higher in the GP than the GS group, and risk factors of HAI were index tumor size ≥ 3 cm and GP use. Clinical relevance C-TACE with GS resulted in the same therapeutic and adverse effects as C-TACE with nonspherical GP while causing significantly less HAI.
引用
- Gwon DI, Chu HH, Kim GH, et al. Conventional transcatheter arterial chemoembolization with gelatin spheres for hepatocellular carcinoma: comparison with nonspherical gelatin sponge particles. Eur Radiol. 2025. PMID: 40146423. doi:10.1007/s00330-025-11527-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。